Merck Serono news from FiercePharma
NewsMore NICE debate over cancer meds
It's not just Roche that refused to fork over cost-effectiveness info on its cancer med to the U.K.'s National Institution for Clinical Health and Excellence. So, too, has Merck Serono. Yesterday,... Read more...
ALSO NOTED: Rebif gets EU nod; Bayer buys Citracal;
> Merck Serono got the EU nod to market a new version of the relapsing multiple sclerosis med Rebif. The new formulation, designed to be better tolerated when injected, will launch next month;... Read more...
| Press ReleasesMerck Serono's Kuvan(R) Recommended for European ApprovalMerck Serono's Kuvan(R) Recommended for European Approval GENEVA, Switzerland, Sep 26, 2008 -- CHMP Issued Positive Opinion Recommending Marketing Authorization of Kuvan(R) for the Treatment of Read more >> Merck Serono's Glucophage(R) Powder for Oral Solution in Sachet Receives Positive Opinion for Approval in EuropeMerck Serono's Glucophage(R) Powder for Oral Solution in Sachet Receives Positive Opinion for Approval in Europe GENEVA, Switzerland, September 10 /PRNewswire/ -- Merck Serono, a division of Merck Read more >> ABLYNX AND MERCK SERONO ENTER INTO AN AGREEMENT TO CO-DISCOVER AND CO- DEVELOP NANOBODIES(R)ABLYNX AND MERCK SERONO ENTER INTO AN AGREEMENT TO CO-DISCOVER AND CO- DEVELOP NANOBODIES(R) GHENT, BELGIUM, Sep 04, 2008 (MARKET WIRE via COMTEX) -- Ablynx and Merck Serono to equally contribute to Read more >> PRESS RELEASE: Merck Serono Exercises Option to Rigel's R763/AS703569 and Aurora Kinase Inhibitors in the Japanese Territory Merck Serono Exercises Option to Rigel's R763/AS703569 and Aurora Kinase Inhibitors in the Japanese Territory SOUTH SAN FRANCISCO, Calif., Nov. 14 -- Rigel Pharmaceuticals, Inc. today announced that Read more >> PRESS RELEASE: New Formulation of Multiple Sclerosis Treatment Rebif(R) Approved in European Union New Formulation of Multiple Sclerosis Treatment Rebif(R) Approved in European Union - New Formulation of Rebif(R) Designed to Improve Injection Tolerability Merck Serono, a division of Merck KGaA, Read more >> |
Get more Merck Serono coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
